From Discovery to the Market

Founded in 2010 by Dr Olivier Loget DVM, ERT CapEval Pharma provides pharmaceutical consultancy services in early pre-clinical to clinical development.


We provide our services all around the world to start-up, big and middle size pharma developing NCE's and NBE's

30 years of experience

We would be very glad to share our network and expertise with you.

Know more about our services

  • Strong experience working with Biotech, Pharma and CRO


  • Expert assessment of both in- and out-licensing programs


  • Extensive experience in due diligence proceeding


  • Public subvention dossier and fundraising


  • Outsourcing management services


Services

Success stories with CapEval

A CNS startup was not able to expose the selected non-rodent, because dogs vomited

CapEval has been able to show that the dog was not the appropriate species and the non-clinical development was successfully completed with minipigs (without vomiting).

During a Due Diligence for a CNS compound supported by CapEval, positive hERG data where identified 

CapEval has been able to implement a derisking cardiac strategy and to use this for negotiating the deal.

A startup had muscle effects in a rat study

CapEval has been able to implement a kinetic follow-up of the findings and to show that this was not relevant to humans.

A startup was about to stop a CNS project because of genotox effects during an in vivo MNT with a metabolite

CapEval has been able to prove that the route of exposure was not appropriate and to derisk the project by changing the route for better mimicking exposure to the metabolite.

Share by: